ArticleCureus2025
Cost Analysis of Postoperative Medications in a Tertiary Care Hospital in Northeast India.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPostoperative medications play a crucial role in managing physiological changes and preventing complications after surgery. However, the cost of these medications can be a significant burden for patients, particularly in low-income settings. This study aimed to estimate the cost of postoperative medications in a tertiary care hospital and simulate the financial burden on patients undergoing elective surgery.
methodsA prospective, hospital-based observational study was conducted at a tertiary care hospital in India. Data were collected from 109 patients undergoing elective surgery, and the cost of medications was calculated using real-world data. A gamma distribution was used to simulate 100000 data points, and the mean, median, and interquartile range of medication costs were estimated.
resultsThe mean medication cost was ₹9332 (around $111 USD), with a median cost of ₹4989 (around $60 USD). The interquartile range was ₹11103, indicating substantial variability in patient costs. The simulation results showed that patients would need to work for an average of 51 days to cover the mean cost of medications, with up to 104 days required for 2.5% of patients.
conclusionThe financial burden of postoperative medications is significant. The findings highlight the need for flexibility in government schemes like Ayushman Bharat to accommodate the variability in costs. Policymakers should consider revising the sanctioned amounts per treatment module to keep pace with inflation and changes in medical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.